Susquehanna International Group
ALNY icon

Susquehanna International Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Susquehanna International Group’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.7M Sell
174,268
-17,552
-9% -$5.97M 0.01% 1182
2025
Q4 		$76.3M Sell
191,820
-385,812
-67% -$171M 0.01% 1053
2025
Q3 		$263M Buy
577,632
+369,370
+177% +$150M 0.03% 449
2025
Q2 		$67.9M Buy
208,262
+137,797
+196% +$38.1M 0.01% 972
2025
Q1 		$19M Buy
70,465
+59,648
+551% +$15.3M ﹤0.01% 1782
2024
Q4 		$2.55M Sell
10,817
-152,917
-93% -$40.2M ﹤0.01% 4780
2024
Q3 		$45M Buy
163,734
+96,723
+144% +$25.2M 0.01% 1170
2024
Q2 		$16.3M Sell
67,011
-14,651
-18% -$2.31M ﹤0.01% 1952
2024
Q1 		$12.2M Buy
81,662
+55,655
+214% +$9.28M ﹤0.01% 2352
2023
Q4 		$4.98M Sell
26,007
-162,346
-86% -$27.7M ﹤0.01% 3702
2023
Q3 		$33.4M Buy
188,353
+98,823
+110% +$18.9M 0.01% 1293
2023
Q2 		$17M Sell
89,530
-24,871
-22% -$4.93M ﹤0.01% 1893
2023
Q1 		$22.9M Buy
114,401
+83,736
+273% +$17.6M ﹤0.01% 1571
2022
Q4 		$7.29M Sell
30,665
-11,752
-28% -$2.51M ﹤0.01% 2699
2022
Q3 		$8.49M Sell
42,417
-21,011
-33% -$4.01M ﹤0.01% 2396
2022
Q2 		$9.25M Sell
63,428
-20,319
-24% -$2.88M ﹤0.01% 2305
2022
Q1 		$13.7M Sell
83,747
-59,208
-41% -$9.02M ﹤0.01% 2138
2021
Q4 		$24.2M Buy
142,955
+98,562
+222% +$18.3M ﹤0.01% 1665
2021
Q3 		$8.38M Sell
44,393
-63,788
-59% -$12M ﹤0.01% 3130
2021
Q2 		$18.3M Buy
108,181
+41,507
+62% +$6.08M ﹤0.01% 2147
2021
Q1 		$9.41M Sell
66,674
-12,254
-16% -$1.84M ﹤0.01% 2872
2020
Q4 		$10.3M Buy
78,928
+40,709
+107% +$5.44M ﹤0.01% 2466
2020
Q3 		$5.56M Buy
38,219
+25,493
+200% +$3.62M ﹤0.01% 2921
2020
Q2 		$1.89M Sell
12,726
-26,153
-67% -$3.53M ﹤0.01% 4608
2020
Q1 		$4.23M Buy
38,879
+402
+1% +$46.4K ﹤0.01% 2795
2019
Q4 		$4.43M Sell
38,477
-69,857
-64% -$6.96M ﹤0.01% 3143
2019
Q3 		$8.71M Buy
108,334
+9,067
+9% +$717K ﹤0.01% 2129
2019
Q2 		$7.2M Buy
99,267
+84,204
+559% +$6.46M ﹤0.01% 2260
2019
Q1 		$1.41M Sell
15,063
-66,766
-82% -$5.58M ﹤0.01% 4340
2018
Q4 		$5.97M Sell
81,829
-7,405
-8% -$570K ﹤0.01% 2101
2018
Q3 		$7.81M Buy
89,234
+48,210
+118% +$4.85M ﹤0.01% 2172
2018
Q2 		$4.04M Buy
41,024
+1,729
+4% +$171K ﹤0.01% 2989
2018
Q1 		$4.68M Sell
39,295
-113,975
-74% -$14.7M ﹤0.01% 2620
2017
Q4 		$19.5M Buy
153,270
+142,394
+1,309% +$17.9M 0.01% 1278
2017
Q3 		$1.28M Sell
10,876
-90,747
-89% -$7.75M ﹤0.01% 4809
2017
Q2 		$8.11M Sell
101,623
-63,375
-38% -$4.05M ﹤0.01% 1880
2017
Q1 		$8.46M Buy
164,998
+25,827
+19% +$1.19M ﹤0.01% 1780
2016
Q4 		$5.21M Buy
+139,171
New +$5.83M ﹤0.01% 2369
2016
Q2 		– Sell
-20,859
Closed -$1.31M – 8481
2016
Q1 		$1.31M Buy
20,859
+1,945
+10% +$129K ﹤0.01% 4544
2015
Q4 		$1.78M Sell
18,914
-138,272
-88% -$12.8M ﹤0.01% 4275
2015
Q3 		$12.6M Buy
157,186
+18,541
+13% +$2.06M 0.01% 1612
2015
Q2 		$16.6M Buy
138,645
+85,034
+159% +$10.2M 0.01% 1484
2015
Q1 		$5.6M Buy
53,611
+41,504
+343% +$4.21M ﹤0.01% 2581
2014
Q4 		$1.17M Sell
12,107
-14,229
-54% -$1.32M ﹤0.01% 5524
2014
Q3 		$2.06M Buy
26,336
+3,828
+17% +$247K ﹤0.01% 4567
2014
Q2 		$1.42M Sell
22,508
-34,377
-60% -$2.04M ﹤0.01% 5337
2014
Q1 		$3.82M Sell
56,885
-3,349
-6% -$259K ﹤0.01% 3283
2013
Q4 		$3.88M Buy
60,234
+34,783
+137% +$2.07M ﹤0.01% 3296
2013
Q3 		$1.63M Buy
+25,451
New +$1.27M ﹤0.01% 4457

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna International Group's ALNY Position: Q1 2026 in Review

Susquehanna International Group reduced its Alnylam Pharmaceuticals (ALNY) stake by 9.2% in Q1 2026, selling an estimated $5.97M and leaving 174,268 shares worth $57.7M. The position accounts for 0.01% of the portfolio, ranked #1182.

Susquehanna International Group first reported a position in ALNY in Q3 2013 and has held it in 49 quarters since. The position peaked at $263M in Q3 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Susquehanna International Group held 174,268 shares of Alnylam Pharmaceuticals worth $57.7M as of Q1 2026.
  • Susquehanna International Group sold 17,552 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $5.97M.
  • Alnylam Pharmaceuticals made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1182 holding.
  • Susquehanna International Group first reported a position in Alnylam Pharmaceuticals in Q3 2013 and has held it in 49 quarters since.
  • Susquehanna International Group's Alnylam Pharmaceuticals position peaked at $263M in Q3 2025.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.